Tailored fluorouracil, epirubicin, and cyclophosphamide compared with marrow-supported high-dose chemotherapy as adjuvant treatment for high-risk breast cancer: a randomised trial-Reference-Cited by-同舟云学术

Tailored fluorouracil, epirubicin, and cyclophosphamide compared with marrow-supported high-dose chemotherapy as adjuvant treatment for high-risk breast cancer: a randomised trial

Published:2000-10 Issue:9239 Volume:356 Page:1384-1391
ISSN:0140-6736
Container-title:The Lancet
language:en
Short-container-title:The Lancet

Author:

Bergh Jonas,Wiklund Tom,Erikstein Björn,Lidbrink Elisabet,Lindman Henrik,Malmström Per,Kellokumpu-Lehtinen Pirkko,Bengtsson Nils-Olof,Söderlund Gustaf,Anker Gun,Wist Erik,Ottosson Susanne,Salminen Eeva,Ljungman Per,Holte Harald,Nilsson Jonas,Blomqvist Carl,Wilking Nils

Publisher

Elsevier BV

Subject

General Medicine

Reference35 articles.

1. Cytotoxic and hormonal treatment for metastatic breast cancer: a systemic review of published randomized trial involving 31,510 women;Fossati;J Clin Oncol,1998

2. Advanced breast cancer high-dose chemotherapy and bone marrow autotransplants;Antman;Ann Intern Med,1988

3. High-dose chemotherapy with autologous hematopoietic stem-cell support for breast cancer in North America;Antman;J Clin Oncol,1997

4. European Group for Blood and Marrow Transplantation (EBMT). In: Rosti G, Ferrante P, eds. Solid tumors working party and registry: Gruppo editoriale faenza editrice s.p.a. edizioni CELI, 1997: 41–53

5. High-dose combination alkylating agents with bone marrow support as initial treatment for metastatic breast cancer;Peters;J Clin Oncol,1988

Cited by 222 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Advanced Body Measurement Techniques Can Complement Current Methods of Cytotoxic Chemotherapy Dose Prescription;Applied Sciences;2024-01-18

2. Chemotherapeutic Protocols for the Treatment of Breast Cancer;Chemotherapy Protocols and Infusion Sequence;2022

3. High-Dose Chemotherapy With Hematopoietic Stem Cell Transplant in Patients With High-Risk Breast Cancer and 4 or More Involved Axillary Lymph Nodes;JAMA Oncology;2020-04-01

4. Impact of chemotherapy-induced neutropenia (CIN) and febrile neutropenia (FN) on cancer treatment outcomes: An overview about well-established and recently emerging clinical data;Critical Reviews in Oncology/Hematology;2017-12

5. Trastuzumab in combination with weekly paclitaxel and carboplatin as neo-adjuvant treatment for HER2-positive breast cancer: The TRAIN-study;European Journal of Cancer;2017-03